A biotechnology company focused on the development and commercialization of immunotherapies. We are a leader in employing Virus-Specific Tcells to treat cancer. Tessa Therapeutics is a clinical stage biopharmaceutical company developing treatment of cancer by redirecting the bodys potent anti-viral immune response to recognize and kill cancer cells.
The National Cancer Centre Singapore, is a strategic shareholder of Tessa and has granted exclusive rights to immuno-oncology technologies to Tessa. The company has exclusive licenses to multiple technologies developed at Baylor College of Medicine.